Unlock your financial potential trading stocks!
October 21, 2019 by Sultan Beardsley
October 13, 2019 by Jason F.
October 11, 2019 by Kevin Douglass
Many of yesterdays trade ideas appear to be poised for continued growth in the coming trading sessions. Read below for updates and new picks for tomorrows session. Futures Prices (%) … [Read More...] about Trade-Ideas Tuesday, Oct. 22nd, 2019
Scynexis (NASDAQ: SCYX) is a clinical stage biotech company based out of New Jersey. The company has one significant drug under development in multiple indications, ibrexafungerp, for the treatment of … [Read More...] about In a Tough Environment for Biotechs, Can the Science at Scynexis Win?
Friday, October 11, 2019 About: ADVERUM BIOTECHNOLOGIES INC (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ADVM is set … [Read More...] about Incoming Data + Gartley
As the month of October begins and broader markets sold off, biotech stocks are still largely negative and/ or flat for the year. As seen in the LABU vs. LABD chart below, the spread between the two … [Read More...] about Biotech: Time To Buy the Bull
This year has been full of positive catalysts for REGENXBIO Inc. (Nasdaq: RGNX). As RGNX continues to build out their clinical pipeline, data catalyst from upcoming phase 2a report on their Wet-AMD … [Read More...] about Upcoming Data And Technical Setup
Puma Biotechnology (NASDAQ: PBYI) is a commercial stage company with an approved oncology drug called Nerlynx, for the treatment of HER2+ breast cancer. The drug was first approved in July 2017, and … [Read More...] about Puma: Surviving, Not Thriving
*90% Of Traders
Lose Money
*100% DON'T
Have To
At MS Money Moves we leverage our teams expertise in science, business, and technical analysis identifying gainful biotech trades.
How we do it?
Patience, Discipline, Objective Analysis.
See our performance record for more info.
Try it for free, Let's get it!
